PiezoWave 2T

Myofascial Acoustic Compression Therapy (MyACT)

The PiezoWave2T succeeds at transforming the mechanical energy of soundwaves into biochemical signals in diseased target tissue. This acoustic compression triggers a cascade of cellular and molecular responses through a process called mechanotransduction.

MyACT induced mechanotransduction supports recovery by stimulating microcirculation through the release of nitric oxide (NO), vasodilation and vascular angiogenesis, increased cellular metabolic rates, as well as providing pain relief via the release of substance P and inflammatory mediators.

The process also releases growth factors (blood vessels, epithelium, bones, collagen, etc.) and stimulates lubricin production and stem cells, thus promoting an environment for enhanced healing and a quicker return to normal activities.